Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia

PURPOSE: To report the efficacy and safety of lower-sodium oxybate (LXB; Xywav(®)) during the open-label titration and optimization period (OLT) and stable-dose period (SDP) in a clinical study for the treatment of idiopathic hypersomnia. PATIENTS AND METHODS: Data were collected during treatment ti...

Descripción completa

Detalles Bibliográficos
Autores principales: Thorpy, Michael J, Arnulf, Isabelle, Foldvary-Schaefer, Nancy, Morse, Anne Marie, Šonka, Karel, Chandler, Patricia, Hickey, Luke, Chen, Abby, Black, Jed, Sterkel, Amanda, Chen, Dan, Bogan, Richard K, Dauvilliers, Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618250/
https://www.ncbi.nlm.nih.gov/pubmed/36320423
http://dx.doi.org/10.2147/NSS.S369122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618250/
https://www.ncbi.nlm.nih.gov/pubmed/36320423
http://dx.doi.org/10.2147/NSS.S369122

Ejemplares similares